Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants

Medicine & Life Sciences

• Anticoagulants 80%
• Health Care Costs 77%
• Atrial Fibrillation 77%
• Stroke 59%
• Hemorrhage 55%
• Embolism 47%
• Costs and Cost Analysis 20%
• Data Warehousing 9%
• Insurance Coverage 7%
• Propensity Score 7%
• Warfarin 7%
• Sample Size 5%
• Hospitalization 4%
• Observation 4%
• Databases 4%
• Mortality 3%

Social Sciences

• stroke 100%
• Healthcare 67%
• major event 49%
• costs 48%
• event 20%
• death 18%
• insurance coverage 15%
• hospitalization 13%
• coding 10%
• mortality 10%